{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:52:49Z","timestamp":1740163969441,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1007718","2021R1F1A1047180"],"award-info":[{"award-number":["NRF-2021R1A2C1007718","2021R1F1A1047180"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To compare pregnancy rates and complications in women with and without a history of optic neuritis (ON). A nationwide, population-based, retrospective study using data from the Korean National Health Claims from January\u00a02011, to December\u00a02017 was done. ON cohort (ON group) consisting of women aged 18 to 50 with a history of ON and 1:3 age-matched controls (control group) were compared for pregnancy and delivery rates using logistic regression after adjusting for possible confounders. Pregnancy-ON cohort (pregnancy-ON group), women aged 18 to 55 with a history of ON and pregnancy, and 1:3 age at pregnancy matched controls (pregnancy-control group) were analyzed for pregnancy complications using logistic regression after adjusting for covariates. ON group (<jats:italic>n<\/jats:italic>\u2009=\u20092516) showed decreased odds ratio (OR) for pregnancy [Adjusted OR2: 0.716, 95% confidence interval (CI): 0.626\u20130.820] and delivery (adjusted OR2: 0.647, 95% CI: 0.554\u20130.756) compared to controls (<jats:italic>n<\/jats:italic>\u2009=\u20097548). Pregnancy-ON group (<jats:italic>n<\/jats:italic>\u2009=\u2009550) showed increased risk of delayed fetal growth (adjusted OR2: 9.867, 95% CI: 1.224\u201379.564), pre-eclampsia (adjusted OR2: 8.327, 95% CI: 2.911\u201323.819), preterm delivery (adjusted OR2: 3.914, 95% CI: 2.667\u20135.742), pregnancy and postpartum infection (adjusted OR1: 1.671, 95% CI: 1.296\u20132.154), diabetes in pregnancy (adjusted OR2: 1.365, 95% CI: 1.062\u20131.754) compared to pregnancy-control group (<jats:italic>n<\/jats:italic>\u2009=\u20091650). Our population-based cohort study suggests that history of ON is associated with decreased pregnancy and delivery rates. It may\u00a0be a risk factor for various pregnancy complications.<\/jats:p>","DOI":"10.1038\/s41598-023-38851-x","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T13:01:36Z","timestamp":1690462896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pregnancy prevalence and outcomes after optic neuritis in South Korea"],"prefix":"10.1038","volume":"13","author":[{"given":"Daye Diana","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ah","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei Yeul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"issue":"2","key":"38851_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.45.2.244","volume":"45","author":"M Rodriguez","year":"1995","unstructured":"Rodriguez, M., Siva, A., Cross, S. A., O\u2019Brien, P. C. & Kurland, L. T. Optic neuritis: A population-based study in Olmsted County, Minnesota. Neurology 45(2), 244\u2013250 (1995).","journal-title":"Neurology"},{"issue":"9","key":"38851_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk, D. M., Lennon, V. A., Lucchinetti, C. F., Pittock, S. J. & Weinshenker, B. G. The spectrum of neuromyelitis optica. Lancet Neurol. 6(9), 805\u2013815. https:\/\/doi.org\/10.1016\/s1474-4422(07)70216-8 (2007).","journal-title":"Lancet Neurol."},{"issue":"12","key":"38851_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11910-019-1014-z","volume":"19","author":"DA Tajfirouz","year":"2019","unstructured":"Tajfirouz, D. A., Bhatti, M. T. & Chen, J. J. Clinical characteristics and treatment of MOG-IgG-associated optic neuritis. Curr. Neurol. Neurosci. 19(12), 100. https:\/\/doi.org\/10.1007\/s11910-019-1014-z (2019).","journal-title":"Curr. Neurol. Neurosci."},{"key":"38851_CR4","doi-asserted-by":"publisher","unstructured":"Optic Neuritis Study Group. The clinical profile of optic neuritis. Experience of the optic neuritis treatment trial. Arch. Ophthalmol. (Chicago, Ill : 1960) 109(12), 1673\u20131678. https:\/\/doi.org\/10.1001\/archopht.1991.01080120057025 (1991).","DOI":"10.1001\/archopht.1991.01080120057025"},{"issue":"2","key":"38851_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0021-5155(98)00072-0","volume":"43","author":"M Wakakura","year":"1999","unstructured":"Wakakura, M. et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan: Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn. J. Ophthalmol. 43(2), 127\u2013132 (1999).","journal-title":"Jpn. J. Ophthalmol."},{"issue":"5","key":"38851_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1046\/j.1442-9071.2001.00442.x","volume":"29","author":"JC Wang","year":"2001","unstructured":"Wang, J. C., Tow, S., Aung, T., Lim, S. A. & Cullen, J. F. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin. Exp. Ophthalmol. 29(5), 312\u2013315 (2001).","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"7","key":"38851_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jocn.2010.11.011","volume":"18","author":"Y Du","year":"2011","unstructured":"Du, Y., Yang, J., Li, J. J., Zhou, R. W. & He, J. F. Unilateral optic neuritis in a Chinese population in three centers. J. Clin. Neurosci. 18(7), 902\u2013904. https:\/\/doi.org\/10.1016\/j.jocn.2010.11.011 (2011).","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"38851_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s1607-551x(09)70457-7","volume":"19","author":"YS Bee","year":"2003","unstructured":"Bee, Y. S., Lin, M. C., Wang, C. C. & Sheu, S. J. Optic neuritis: Clinical analysis of 27 cases. Kaohsiung J. Med. Sci. 19(3), 105\u2013112. https:\/\/doi.org\/10.1016\/s1607-551x(09)70457-7 (2003).","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"3","key":"38851_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","volume":"35","author":"ST Ngo","year":"2014","unstructured":"Ngo, S. T., Steyn, F. J. & McCombe, P. A. Gender differences in autoimmune disease. Front. Neuroendocrinol. 35(3), 347\u2013369. https:\/\/doi.org\/10.1016\/j.yfrne.2014.04.004 (2014).","journal-title":"Front. Neuroendocrinol."},{"issue":"5","key":"38851_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/1352458508101937","volume":"15","author":"YH Chen","year":"2009","unstructured":"Chen, Y. H., Lin, H. L. & Lin, H. C. Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study. Mult. Scler. (Houndmills, Basingstoke, England) 15(5), 606\u2013612. https:\/\/doi.org\/10.1177\/1352458508101937 (2009).","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)"},{"issue":"1","key":"38851_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/aje\/kwy197","volume":"188","author":"SC MacDonald","year":"2019","unstructured":"MacDonald, S. C., McElrath, T. F. & Hernandez-Diaz, S. Pregnancy outcomes in women with multiple sclerosis. Am. J. Epidemiol. 188(1), 57\u201366. https:\/\/doi.org\/10.1093\/aje\/kwy197 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"38851_CR12","doi-asserted-by":"publisher","first-page":"102682","DOI":"10.1016\/j.msard.2020.102682","volume":"48","author":"B Soler","year":"2021","unstructured":"Soler, B. et al. Pregnancy outcomes in women with Multiple Sclerosis. Mult. Scler. Relat. Disord. 48, 102682. https:\/\/doi.org\/10.1016\/j.msard.2020.102682 (2021).","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"17","key":"38851_CR13","doi-asserted-by":"publisher","first-page":"e1559","DOI":"10.1212\/WNL.0000000000006384","volume":"91","author":"MK Houtchens","year":"2018","unstructured":"Houtchens, M. K., Edwards, N. C., Schneider, G., Stern, K. & Phillips, A. L. Pregnancy rates and outcomes in women with and without MS in the United States. Neurology 91(17), e1559\u2013e1569. https:\/\/doi.org\/10.1212\/WNL.0000000000006384 (2018).","journal-title":"Neurology"},{"issue":"1","key":"38851_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1212\/WNL.0000000000002208","volume":"86","author":"MM Nour","year":"2016","unstructured":"Nour, M. M. et al. Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder. Neurology 86(1), 79\u201387. https:\/\/doi.org\/10.1212\/WNL.0000000000002208 (2016).","journal-title":"Neurology"},{"issue":"4","key":"38851_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00415-014-7266-2","volume":"261","author":"EH Martinez-Lapiscina","year":"2014","unstructured":"Martinez-Lapiscina, E. H. et al. Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008\u20132012. J. Neurol. 261(4), 759\u2013767. https:\/\/doi.org\/10.1007\/s00415-014-7266-2 (2014).","journal-title":"J. Neurol."},{"issue":"7","key":"38851_CR16","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/eye.2011.81","volume":"25","author":"D Pau","year":"2011","unstructured":"Pau, D., Al Zubidi, N., Yalamanchili, S., Plant, G. T. & Lee, A. G. Optic neuritis. Eye (Lond) 25(7), 833\u2013842. https:\/\/doi.org\/10.1038\/eye.2011.81 (2011).","journal-title":"Eye (Lond)"},{"issue":"2","key":"38851_CR17","doi-asserted-by":"publisher","first-page":"e1000369","DOI":"10.1371\/journal.pgen.1000369","volume":"5","author":"SV Ramagopalan","year":"2009","unstructured":"Ramagopalan, S. V. et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 5(2), e1000369. https:\/\/doi.org\/10.1371\/journal.pgen.1000369 (2009).","journal-title":"PLoS Genet."},{"issue":"1","key":"38851_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/14397595.2013.854059","volume":"24","author":"H Yamanaka","year":"2014","unstructured":"Yamanaka, H., Sugiyama, N., Inoue, E., Taniguchi, A. & Momohara, S. Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I). Mod. Rheumatol. 24(1), 33\u201340. https:\/\/doi.org\/10.3109\/14397595.2013.854059 (2014).","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"38851_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00415-015-7663-1","volume":"262","author":"T Roux","year":"2015","unstructured":"Roux, T. et al. Fecundity in women with multiple sclerosis: An observational mono-centric study. J. Neurol. 262(4), 957\u2013960. https:\/\/doi.org\/10.1007\/s00415-015-7663-1 (2015).","journal-title":"J. Neurol."},{"issue":"4","key":"38851_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1743-6109.2010.02161.x","volume":"8","author":"G Lombardi","year":"2011","unstructured":"Lombardi, G., Celso, M., Bartelli, M., Cilotti, A. & Del Popolo, G. Female sexual dysfunction and hormonal status in multiple sclerosis patients. J. Sex Med. 8(4), 1138\u20131146. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.02161.x (2011).","journal-title":"J. Sex Med."},{"issue":"3","key":"38851_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/14767058.2017.1286314","volume":"31","author":"A Fong","year":"2018","unstructured":"Fong, A. et al. Multiple sclerosis in pregnancy: Prevalence, sociodemographic features, and obstetrical outcomes. J. Matern. Fetal Neonatal Med. 31(3), 382\u2013387. https:\/\/doi.org\/10.1080\/14767058.2017.1286314 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"issue":"Suppl 1","key":"38851_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000367640","volume":"72","author":"K Hellwig","year":"2014","unstructured":"Hellwig, K. Pregnancy in multiple sclerosis. Eur. Neurol. 72(Suppl 1), 39\u201342. https:\/\/doi.org\/10.1159\/000367640 (2014).","journal-title":"Eur. Neurol."},{"key":"38851_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211035376","author":"H Tillaut","year":"2021","unstructured":"Tillaut, H. et al. Pregnancy in women with multiple sclerosis in France from 2010 to 2015: Incidence, outcomes, and exposure to disease-modifying therapies. Mult. Scler. https:\/\/doi.org\/10.1177\/13524585211035376 (2021).","journal-title":"Mult. Scler."},{"issue":"9","key":"38851_CR24","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s40279-017-0709-z","volume":"47","author":"MA Christou","year":"2017","unstructured":"Christou, M. A. et al. Effects of anabolic androgenic steroids on the reproductive system of athletes and recreational users: A systematic review and meta-analysis. Sports Med. 47(9), 1869\u20131883. https:\/\/doi.org\/10.1007\/s40279-017-0709-z (2017).","journal-title":"Sports Med."},{"issue":"3","key":"38851_CR25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1517\/14740338.7.3.219","volume":"7","author":"CN Pisoni","year":"2008","unstructured":"Pisoni, C. N. & D\u2019Cruz, D. P. The safety of mycophenolate mofetil in pregnancy. Expert Opin. Drug Saf. 7(3), 219\u2013222. https:\/\/doi.org\/10.1517\/14740338.7.3.219 (2008).","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"38851_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/09513590701259542","volume":"23","author":"M Abalovich","year":"2007","unstructured":"Abalovich, M. et al. Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol. Endocrinol. 23(5), 279\u2013283. https:\/\/doi.org\/10.1080\/09513590701259542 (2007).","journal-title":"Gynecol. Endocrinol."},{"key":"38851_CR27","doi-asserted-by":"publisher","first-page":"982705","DOI":"10.1155\/2014\/982705","volume":"2014","author":"A Quintino-Moro","year":"2014","unstructured":"Quintino-Moro, A., Zantut-Wittmann, D. E., Tambascia, M., Machado Hda, C. & Fernandes, A. High prevalence of infertility among women with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Int. J. Endocrinol. 2014, 982705. https:\/\/doi.org\/10.1155\/2014\/982705 (2014).","journal-title":"Int. J. Endocrinol."},{"issue":"6","key":"38851_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1600-0897.1999.tb00110.x","volume":"42","author":"AS Kaider","year":"1999","unstructured":"Kaider, A. S., Kaider, B. D., Janowicz, P. B. & Roussev, R. G. Immunodiagnostic evaluation in women with reproductive failure. Am. J. Reprod. Immunol. 42(6), 335\u2013346. https:\/\/doi.org\/10.1111\/j.1600-0897.1999.tb00110.x (1999).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5\u20136","key":"38851_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-0897.2006.00434.x","volume":"56","author":"Y Shoenfeld","year":"2006","unstructured":"Shoenfeld, Y. et al. Autoantibodies and prediction of reproductive failure. Am. J. Reprod. Immunol. 56(5\u20136), 337\u2013344. https:\/\/doi.org\/10.1111\/j.1600-0897.2006.00434.x (2006).","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5 Suppl 1","key":"38851_CR30","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.fertnstert.2006.07.1475","volume":"86","author":"Practice Committee of the American Society for Reproductive M","year":"2006","unstructured":"Practice Committee of the American Society for Reproductive M. Effectiveness and treatment for unexplained infertility. Fertil. Steril. 86(5 Suppl 1), S111-114. https:\/\/doi.org\/10.1016\/j.fertnstert.2006.07.1475 (2006).","journal-title":"Fertil. Steril."},{"issue":"5","key":"38851_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/molehr\/gal032","volume":"12","author":"MJ Jasper","year":"2006","unstructured":"Jasper, M. J., Tremellen, K. P. & Robertson, S. A. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol. Hum. Reprod. 12(5), 301\u2013308. https:\/\/doi.org\/10.1093\/molehr\/gal032 (2006).","journal-title":"Mol. Hum. Reprod."},{"issue":"17","key":"38851_CR32","doi-asserted-by":"publisher","first-page":"e1570","DOI":"10.1212\/WNL.0000000000006382","volume":"91","author":"MK Houtchens","year":"2018","unstructured":"Houtchens, M. K., Edwards, N. C. & Phillips, A. L. Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS. Neurology 91(17), e1570\u2013e1578. https:\/\/doi.org\/10.1212\/WNL.0000000000006382 (2018).","journal-title":"Neurology"},{"issue":"3","key":"38851_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1067\/mob.2002.120502","volume":"186","author":"BA Mueller","year":"2002","unstructured":"Mueller, B. A., Zhang, J. & Critchlow, C. W. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am. J. Obstet. Gynecol. 186(3), 446\u2013452. https:\/\/doi.org\/10.1067\/mob.2002.120502 (2002).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"38851_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jns.2018.01.040","volume":"387","author":"Y Chang","year":"2018","unstructured":"Chang, Y. et al. Study of the placentae of patients with neuromyelitis optica spectrum disorder. J. Neurol. Sci. 387, 119\u2013123. https:\/\/doi.org\/10.1016\/j.jns.2018.01.040 (2018).","journal-title":"J. Neurol. Sci."},{"key":"38851_CR35","doi-asserted-by":"publisher","first-page":"b4026","DOI":"10.1136\/bmj.b4026","volume":"339","author":"R Reuss","year":"2009","unstructured":"Reuss, R. et al. A woman with acute myelopathy in pregnancy: Case outcome. BMJ 339, b4026. https:\/\/doi.org\/10.1136\/bmj.b4026 (2009).","journal-title":"BMJ"},{"issue":"6","key":"38851_CR36","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.1301483","volume":"191","author":"S Saadoun","year":"2013","unstructured":"Saadoun, S. et al. Neuromyelitis optica IgG causes placental inflammation and fetal death. J. Immunol. 191(6), 2999\u20133005. https:\/\/doi.org\/10.4049\/jimmunol.1301483 (2013).","journal-title":"J. Immunol."},{"issue":"2","key":"38851_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ogc.2004.03.007","volume":"31","author":"JB Warren","year":"2004","unstructured":"Warren, J. B. & Silver, R. M. Autoimmune disease in pregnancy: Systemic lupus erythematosus and antiphospholipid syndrome. Obstet. Gynecol. Clin. N. Am. 31(2), 345\u2013372. https:\/\/doi.org\/10.1016\/j.ogc.2004.03.007 (2004) (vi\u2013vii).","journal-title":"Obstet. Gynecol. Clin. N. Am."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38851-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38851-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T13:11:22Z","timestamp":1690463482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-38851-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38851"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-38851-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2023,7,27]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12167"}}